Expression of Tansketolase TKTL1 in Iraqi Breast Cancer Females

Main Article Content

Hanan Kahdum Ali
Wafaa Sabri Mahood


Trasketolase, , Breast cancer, Gene expression, Iraq


Background: Breast cancer is the second leading cause of cancer death among women around the world.TKTL1 is major enzyme in the non oxidative reaction in the pentose phosphate pathway (PPP) pathway lead to lactate production and only increases aerobic glycolysis that contributes to carcinogenesis. The aim of this study is to investigate the TKTL1gene expression in breast cancer patients and its relationship with patients clinical characteristics. . Methods: The study included detection of TKTL1gene expression in 50 Iraqi breast cancer patients and 25 healthy controls using qPCR technology.
Results: Increasing level of folding gene expression (FE) for the TKTL1 gene compared to the control group was found in breast cancer females. No significant differences in TKTL1 gene expression depend ages were found in this study. It was observed that the level of FE on the right side increased by an average 5.06 in 46% (23/50) compared with 4.22 fold on the left side in 54 % (27/50). Significant differences depending on the tumor site (P≤0.05) were observed in this study. An increase of FE (4.96) for the TKTL1 gene was found in Invasive Ductal Carcinomas (IDC) of breast tumors with a significant association. The results also showed a high rate of TKTL1 FE (4.65) in 78% (39/50) of patients with The second grade of tumor compared to (1.48) in the control group with high significant association (P≤0.01). A significant association between FE of TKTL1 gene expression and tumor grade (P≤0.01). The results refer to an increase of FE (6.39) for KTL1gene in 12% (6/50) and (4.90) in 42% (50/21) patients with stage I stage and II respectively The results were showed significant differences depending on breast cancer stage (P≤0.01).
Conclusions: High level of TKTL1gene expression gene was found in Iraqi females with breast cancer with significant relation depending on site, type, second grade, and stage of breast cancer on the right side. The study indicated that the expression of TKTL1gene maybe act as a biomarker for early detection of breast cancer.

Abstract 165 | PDF Downloads 159


1. Lilleborge, M., Falk, R. S., Sørlie, T., Ursin, G., & Hofvind, S. Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion.2021; International Journal of Cancer, 149(6) : 1247-1256.
2. Wu, J., & Hicks, C. Breast Cancer Type Classification Using Machine Learning.2021; Journal of personalized medicine, 11(2): 61.
3. Al-Gburi, A. S., Alwan, N. A., Al-Tameemi, E. A. K., & Al-Dabbagh, W. H. Opportunistic Screening for Early Detection of Breast Cancer in Iraq.2021; International Medical Journal, 28(1): 28-32.
4. Qin, Z., Xiang, C., Zhong, F., Liu, Y., Dong, Q., Li, K., ... & He, F. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.2019; Journal of Experimental & Clinical Cancer Research, 38(1): 1-21
5. Alfarouk, K. O., Ahmed, S., Elliott, R. L., Benoit, A., Alqahtani, S. S., Ibrahim, M. E., ... & Reshkin, S. J. (2020). The pentose phosphate pathway dynamics in cancer and its dependency on intracellular pH.2020; Metabolites, 10(7): 285.
6. Ge, T., Yang, J., Zhou, S., Wang, Y., Li, Y., & Tong, X. The role of the pentose phosphate pathway in diabetes and cancer.2020; Frontiers in Endocrinology, 11, 365.
7. Zhang, S., Yue, J. X., Yang, J. H., Cai, P. C., & Kong, W. J. Overexpression of transketolase protein TKTL1 is associated with occurrence and progression in nasopharyngeal carcinoma: a potential therapeutic target in nasopharyngeal carcinoma.2008; Cancer biology & therapy, 7(4) : 517-522.
8. Saman, S., Stagno, M. J., Warmann, S. W., Malek, N. P., Plentz, R. R., & Schmid, E. Biomarkers Apo10 and TKTL1: Epitope-detection in monocytes (EDIM) as a new diagnostic approach for cholangiocellular, pancreatic and colorectal carcinoma.2020; Cancer Biomarkers, 27(1) :129-137.
9. Jayachandran , A., Lo, P. H., Chueh, A. C., Prithviraj, P., Molania, R., Davalos-Salas, M., Anaka, M., Walkiewicz, M., Cebon, J., & Behren, A. Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.2016; BMC cancer, 16, 134.
10. Mahood1,W.S., Mohammed, M.J., Mayyahi ,M.T. .AL Musawi,I..N , Abdel-Jabbar, B.A. High Spectrum of PTEN Gene Mutations in Iraqi Breast Cancer Patients.2018; Journal of Global Pharma Technology 10(11) (Suppl.) 242-248.
11. Kammerer, U., Gires, O., Pfetzer, N., Wiegering, A., Klement, R. J., & Otto, C. TKTL1 expression in human malign and benign cell lines.2015; BMC cancer, 15: 2.
12. Rostkowska-Nadolska, B.; Kapral, M.; Mazurek , U.; Gawron, W. and Preś, K. Co-expression of the TGF-β1 and TGF-β2 isoforms in nasal polyps and in healthy mucosa. Postepy.2007; Hig. Med. Dosw. (online), 61: 702-707.
13. Ahopelto, K., Laitinen, A., Hagström, J., Böckelman, C., & Haglund, C. Transketolase-like protein 1 and glucose transporter 1 in gastric cancer.2020; Oncology, 98(9): 643-652.
14. Ahopelto, K., Böckelman, C., Hagström, J., Koskensalo, S., & Haglund, C. Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer.2016; Cancer biology & therapy, 17(2): 163–168.
15. Sun, W., Liu, Y., Glazer, C. A., Shao, C., Bhan, S., Demokan, S., & Califano, J. A. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1α stabilization.2010; Clinical Cancer Research, 16(3): 857-866
16. Zhu, X., Xuan, Z., Chen, J., Li, Z., Zheng, S., & Song, P. How DNA methylation affects the Warburg effect.2020; International journal of biological sciences, 16(12), 2029.
17. Schmidt, M., Voelker, H. U., Kapp, M., Krockenberger, M., Dietl, J., & Kammerer, U. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK.2010; Journal of cancer research and clinical oncology, 136(2): 219-225.
18. Costa, I. A., Hennenlotter, J., Stühler, V., Kühs, U., Scharpf, M., Todenhöfer, T., ... & Bedke, J. Transketolase like 1 (TKTL1) expression alterations in prostate cancer tumorigenesis.2018; In Urologic Oncology: Seminars and Original Investigations,36(10):472-e21.
19. Lange, C. A., Tisch-Rottensteiner, J., Böhringer, D., Martin, G., Schwartzkopff, J., & Auw-Haedrich, C. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome.2012; Ophthalmology, 119(9): 1924-1929
20. Foldi, M., Stickeler, E., Bau, L., Kretz, O., Watermann, D., Gitsch, G., ... & Coy, J. F. Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer.2007; Oncology reports, 17(4): 841-845.
21. Zhao, M., Ye, M., Zhou, J., & Zhu, X. Prognostic values of transketolase family genes in ovarian cancer.2019; Oncology letters, 18(5): 48.
22. Diaz-Moralli, S., Tarrado-Castellarnau, M., Alenda, C., Castells, A., & Cascante, M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation.2011; PloS one, 6(9): e25323.
23. Zhang, S., Yang, J. H., Guo, C. K., & Cai, P. C. Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells.2007; Cancer letters, 253(1): 108-114
24. Krockenberger, M., Engel, J. B., Schmidt, M., Kohrenhagen, N., Häusler, S. F. M., Dombrowski, Y., ... & Honig, A. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer.2010; Anticancer research, 30(5): 1653-1659. pH.2020; Metabolites, 10(7): 285.